双磷酸盐相关颌骨骨坏死1例报道及文献复习
被引量:2
摘要
双磷酸盐已被证实能有效地缓解湿疹样乳腺癌、骨质疏松症等疾病所致的高钙血症、病理性骨折、脊髓压迫等严重并发症,延长患者的生存时间,改善生活质量。自双磷酸盐相关颌骨骨坏死(bisphos-phonate-related osteonecrosis of the jaws,BRONJ)作为双磷酸盐的并发症首次报道以来,其成因、诊断、治疗等相关的临床及实验室研究方兴未艾[1]。
出处
《全科医学临床与教育》
2013年第4期465-467,共3页
Clinical Education of General Practice
参考文献25
-
1Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induce avascular necrosis of the jaws: a growing epidemic[J]. Oral Maxillofac Surg, 2003,61 (9) : 1115-1117.
-
2Scheper MA, Chaisuparat R,Cullen KJ,et al. A novel softtissue in vitro model for bisphosphonate-associated osteone- crosis[J]. Fibrogenesis & Tissue Repair, 2010,3 ( 1 ) : 6-16.
-
3Kim RH, Lee RS, Williams D, et al. Bisphosphonates induce senescence in normal human oral keratinocytes [J]. Dent Res ,2011,90(6) :810-816.
-
4Ana OH. Frequency and risk factors associated with os- teonecrosis of the jaw in cancer patients treated with intra- venous bisphosphonates[J]. Journal of Bone and Mineral Re- search, 2008,23 (6) : 826-836.
-
5Matthew RA.Bisphosphonates and osteonecrosis of the jaw: moving from the bedside to the bencb[J].Cell Tissues Or- gans, 2009, 189(1-4) : 289-294.
-
6Fellows JL, Rindal DB, Barasch A,et al. ONJ in two dental practice-based research network regions [J]. Dent Res, 2011,90(4) :433-438.
-
7Barasch A,Cunha-Cruz J,Curro FA,et al. Risk Factors for osteonecrosis of the Jaws:a case-control study from the condor dental pbrn[J].Dent Res, 2011,90(4) : 439-444.
-
8Nicolau CN, Bastos AS, Spolidorio LC, et al. Long-term treatment with alendronate increases the surgical difficulty during simple exodontias-an in vivo observation in Hohz- man rats[J].Head Face Med, 2012,8 ( 1 ) :20-23.
-
9Corso A,Varettoni M,Zappasodi P, et al.A different sched- ule of zoledronic acid can reduce the r/sk of the osteonecro- sis of the jaw in patients with multiple myeloma [J]. Leukemia, 2007,21 ( 7 ) : 1545-1548.
-
10Gelsomina LB, Caroline B, John GC, et al.Is bisphospho- nate therapy for benign bone disease associated with im- paired dental healing?A case-controlled study[J].BMC Mus- culoskeletal Disorders, 2011,12( 1 ) : 71-80.
二级参考文献92
-
1阮敏,季彤,张陈平.双膦酸盐性颌骨坏死的研究进展[J].上海口腔医学,2006,15(6):663-667. 被引量:6
-
2Kyle RA, Yee GC, Somerfield MR, et al. American Society of Clinical Oncology 2007 clinical practice guideline update on the role of bisphosphonates in multiple myeloma. J Ctin Oncol, 2007, 25: 2464-2472.
-
3Hillner BE, Ingle JN, Chlebowski RT, et al. American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer. J Clin Oncol, 2003, 21:4042-4057.
-
4Berry S, Waldron T, Winquist E, et al. The use of bisphosphonates in men with hormone-refractory prostate cancer: a systematic review of randomized trials. Can J Urol, 2006,13:3180-3188.
-
5Brown JP, Josse RG. Scientific Advisory Council of the Osteoporosis Society of Canada. 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ, 2002, 167 (Suppl) : S 1 -S34.
-
6Dimopoulos MA, Kastritis E, Anagnostopoulos A, et al. Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates : Evidence of increased risk after treatment with zoledronic acid. Haematologica, 2006,91:968-971.
-
7Durie BG, Katz M, Crowley J. Osteonecrosis of the jaws and bisphosphonates. N Engl J Med, 2005,353:99-102.
-
8Hoff AO, Toth BB, Altundag K, et al. Osteonecrosis of the jaw in patients receiving intravenous bisphosphonate therapy. ASCO Annual Meeting Proceedings (post meeting edition). J Clin Oncol, 2006,24: 8528.
-
9Pozzi S, Marcheselli R, Sacchi S. Analysis of frequency and risk factors for developing bisphosphonate associated necrosis of the jaw. American Society of Hematology Annual Meeting [ abstract ]. Blood, 2005:5057.
-
10Tosi P, Zamagni E, Cangini D. Bisphosphonates and osteonecrosis of the jaws : Incidence in a homogeneous series of patien ts with newly diagnosed multiple myeloma treated with zoledronic acid. American Society of Hematology Annual Meeting [ abstract ]. Blood, 2005 : 3461.
共引文献21
-
1许洁,丁玉.唑来膦酸治疗糖皮质激素所致骨质疏松症的护理[J].江苏医药,2012,38(16):1979-1980. 被引量:2
-
2盛璐,文建民,童昕.双磷酸盐相关性颌骨坏死1例报道及文献复习[J].广东牙病防治,2013,21(12):660-662. 被引量:5
-
3戎佩佩,宋金春,吴玥,李萌.临床药师对23例乳腺癌骨转移患者的药学服务[J].中国药房,2014,25(38):3646-3648. 被引量:2
-
4凌翰彬,蒋宇亮,李致媛,钟玲,刘博,黎奔.双膦酸盐类药物致不良反应回顾性分析[J].现代生物医学进展,2014,14(35):6963-6966. 被引量:6
-
5郎淼杰,周稚辉,毛静静,任曼曼,朱莉,王彦亮.唑来膦酸对血管内皮细胞损伤的影响[J].中华口腔医学杂志,2015,50(7):399-402. 被引量:4
-
6宋志强,董伟,阴露佳,刘娟娟,孙红,戚孟春.沙利度胺对双膦酸盐相关颌骨坏死的影响[J].南方医科大学学报,2015,35(8):1084-1089. 被引量:3
-
7郎淼杰,周稚辉,叶鹏程,王彦亮.双膦酸盐致颌骨坏死的研究进展[J].口腔医学,2016,36(4):373-376. 被引量:1
-
8张学伟,刘浩,陈瑞扬,张萍,杨立,吴炜,严颖彬.双膦酸盐相关性颌骨坏死9例临床分析[J].中国口腔颌面外科杂志,2016,14(5):449-454. 被引量:2
-
9高乐女,钟兵,王勇.锝[^(99)Tc]亚甲基二膦酸盐治疗骨质疏松症的研究进展[J].中国骨质疏松杂志,2017,23(8):1094-1099. 被引量:14
-
10李萌宇,王绍义.双膦酸盐相关性颌骨坏死的发生机制与风险评估[J].口腔医学,2017,37(9):849-853. 被引量:9
同被引文献50
-
1佘毅,苟晓琴,安振梅,李双庆.帕米膦酸二钠致高热1例并文献复习[J].华西医学,2008,23(6). 被引量:1
-
2李丹,乙苏北,王岩.帕米膦酸二钠治疗乳癌骨转移致腹泻3例[J].药物不良反应杂志,2004,6(5):339-339. 被引量:1
-
3管玫,吴锐,陈泽莲.依替膦酸二钠致黄疸和严重肝损害[J].药物不良反应杂志,2005,7(4):294-294. 被引量:2
-
4孙明霞,赵玉亮,林蓉燕,王晓云,金瑢.帕米膦酸二钠治疗骨转移癌致上颌骨坏死一例[J].中国肿瘤临床与康复,2006,13(2). 被引量:3
-
5曹永红.唑来膦酸钠注射剂致低钙血症2例[J].中国药师,2007,10(4):372-372. 被引量:8
-
6周冀平,梁秀敏.帕米膦酸二钠致高热1例[J].中国综合临床,2007,23(9):844-844. 被引量:2
-
7吴宁,葛才荣.双膦酸盐类药物的临床应用进展[J].中国误诊学杂志,2007,7(16):3707-3709. 被引量:6
-
8Hansen T, Kirkpatrick CJ, Waiter C, et ai. Increased numbers of osteoclasts expressing cysteine proteinase cathepsin K in patients with infected osteoradionecrosis and bisphosphonate : associated osteonecrosis : a paradoxical observation[J].Virchows Arch, 2006, 449(4):448-454.
-
9Kuroshima S, Go VA, Yamashita J. Increased numbers of nonattached osteoclasts after long-term zoledronic acid therapy in mice[J]. Endocrinology, 2012,153(1):17-28.
-
10Vigorita VJ, Silver JS, Eisemon EO. Osteoclast abnormalities in fractured bone during bisphosphonate treatment for osteoporosis: a case report[J].Skeletai Radiol, 2012, 41(7): 861-865.
引证文献2
-
1凌翰彬,蒋宇亮,李致媛,钟玲,刘博,黎奔.双膦酸盐类药物致不良反应回顾性分析[J].现代生物医学进展,2014,14(35):6963-6966. 被引量:6
-
2郎淼杰,周稚辉,毛静静,任曼曼,朱莉,王彦亮.唑来膦酸对血管内皮细胞损伤的影响[J].中华口腔医学杂志,2015,50(7):399-402. 被引量:4
二级引证文献10
-
1王颖,郑炜,张继胜,刘小平,马俊福,朱跃兰,侯秀娟.双膦酸盐在风湿类疾病中的应用进展[J].风湿病与关节炎,2016,5(2):58-62. 被引量:5
-
2黄艳,高宾.帕米磷酸二钠治疗儿童成骨不全不良反应的护理效果[J].检验医学与临床,2017,14(4):550-552. 被引量:5
-
3卢园华,张鹰庆,蓝丹莉.几种双膦酸盐类药物使用跟踪[J].海峡药学,2017,29(11):258-259. 被引量:1
-
4张长彪,彭冉东,赵军,邓强,李中锋,关新红,张秀.益肾地黄汤联合利塞膦酸钠治疗肾阳虚型绝经后骨质疏松症45例[J].西部中医药,2017,30(4):1-4. 被引量:3
-
5苟静,岳建彪,李霞,索钢.伊班膦酸钠联合唑来膦酸治疗绝经后骨质疏松症患者的临床效果及对生活质量的影响[J].疑难病杂志,2019,18(4):383-387. 被引量:23
-
6杨雪佳,胡靖,张媛媛,刘艳静,董秋立,李明芳.盐酸法舒地尔对PCI术后慢血流冠心病患者内皮细胞损伤的作用及其机制研究[J].中国现代医学杂志,2020,30(13):31-36. 被引量:14
-
7吴平凡,李羽,雷振革,陈林林.种植体引起双膦酸盐相关性下颌骨坏死1例[J].华西口腔医学杂志,2020,38(4):460-463. 被引量:3
-
8邱越桦,王海燕.富组蛋白1在基础研究中的研究进展[J].中国医药科学,2021,11(1):55-58. 被引量:1
-
9刘鹏,尤海玲,冯高飞,陈宝燕.唑来膦酸注射液致Ⅳ度粒细胞缺乏症1例[J].医药导报,2021,40(7):954-956. 被引量:2
-
10王一名,薛洋,赵吉宏,潘剑,邹多宏,崔念晖,张伟,王杞章,李志政,周驭穹,胡开进.漫步牙槽光辉岁月勇踏实践创新征途[J].中华口腔医学杂志,2024,59(4):301-311.
-
1庄稼英.双膦酸盐致颌骨骨坏死[J].糖尿病天地(临床),2011(7):319-321.
-
2张勇,李昀生.二磷酸盐与颌骨骨坏死相关性的研究进展[J].当代医学,2011,17(7):20-22. 被引量:1
-
3马泽云,王衣祥.二膦酸盐相关颌骨骨坏死发病理论进展[J].中华口腔医学杂志,2014,49(2):125-126. 被引量:4
-
4许光普,刘均墀,曾宗渊.双皮岛游离皮瓣移植治疗放射性颌骨骨坏死[J].癌症,1996,15(4):318-318. 被引量:1
-
5刘春玲,姜家豫.肺癌合并高钙血症的防治[J].新疆医学,2004,34(4):113-114. 被引量:1
-
6房娜,张宁,崔新建.核素骨扫描及PET显像诊断骨转移瘤的价值[J].齐鲁医学杂志,2009,24(1):85-86. 被引量:5
-
7运动损伤的药物治疗[J].广东审计,2006,0(4):51-51.
-
8胡雪珍,黄海清,邓新达.脊髓压迫的常规X线检查和CT诊断价值探讨[J].河北医学,2000,6(11):1015-1015.
-
9王萌,崔亚利.放射性药物在治疗骨转移瘤中的应用[J].实用肿瘤学杂志,2008,22(4):391-392. 被引量:9
-
10李利红,吴学宾,陈文明,陈建新,吴垠,陈世伦.多发性骨髓瘤使用双磷酸盐引起颌骨坏死四例[J].中华医学杂志,2008,88(42):2986-2987. 被引量:4